Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

Efficacy, Safety, Tolerability and Pharmacokinetics of SUN13837 to Treat Acute Stroke

ClinicalTrials.gov ID: NCT02258880

Public ClinicalTrials.gov record NCT02258880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SUN13837 Administered 28 Doses (27/28 Days) to Adult Subjects With an Acute Ischemic Stroke

Study identification

NCT ID
NCT02258880
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • SUN13837 Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2014
Primary completion
Apr 30, 2016
Completion
Apr 30, 2016
Last update posted
Oct 19, 2015

2014 – 2016

United States locations

U.S. sites
37
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Not listed Mobile Alabama 36693
Not listed Encinita California 92024
Not listed Oceanside California 92056
Not listed Sarasota Florida 34239
Not listed Tampa Florida 33606
Not listed Atlanta Georgia 30322
Not listed Savannah Georgia 31405
Not listed Lexington Kentucky 40536
Not listed Marrero Louisiana 70072
Not listed New Orleans Louisiana 70112
Not listed New Orleans Louisiana 70121
Not listed Worcester Massachusetts 01655
Not listed Detroit Michigan 48201
Not listed Detroit Michigan 48236
Not listed Novi Michigan 48374
Not listed Southfield Michigan 48705
Not listed Kalispell Montana 59901
Not listed Reno Nevada 89502
Not listed Edison New Jersey 08818
Not listed Summit New Jersey 07901
Not listed Brooklyn New York 11220
Not listed Chapel Hill North Carolina 27599
Not listed Columbus Ohio 43210
Not listed Portland Oregon 97201
Not listed Portland Oregon 97213
Not listed Portland Oregon 97225
Not listed Bryn Mawr Pennsylvania 19010
Not listed Hershey Pennsylvania 17033
Not listed Paoli Pennsylvania 19301
Not listed Philadelphia Pennsylvania 19102
Not listed Columbia South Carolina 29203
Not listed Chattanooga Tennessee 37404
Not listed Houston Texas 77030
Not listed Mechanicsville Virginia 23116
Not listed Midlothian Virginia 23114
Not listed Richmond Virginia 23226
Not listed Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02258880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2015 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02258880 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →